L-Glutaminase is an enzyme of marked significance in biotechnology, with applications ranging from therapeutic interventions in cancer treatment to the enhancement of umami flavour in fermented foods.

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

Centuries before biotechnology had a name, humans were already practicing it – breeding animals for resilience, fermenting foods and treating pain with plants. Today, that same spirit of discovery ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

April M. Kloxin, professor of chemical and biomolecular engineering and materials science and engineering at the University of Delaware, has been named director of the Delaware Biotechnology Institute ...

Wacker Chemie has opened its Wacker Biotechnology Center in Munich, in which the company has invested a double-digit million-euro sum in the facility. “The Wacker Biotech Center will allow us to ...

BiotechLabzSupply.com has implemented inventory management systems designed to support structured procurement forecasting and ...

This new book by the National Research Council recommends that the government expand existing regulations and rely on self-governance by scientists rather than adopt intrusive new policies. One key ...

Biotech Labz Supply has revealed an exciting enhancement of its product range, concentrating on research peptides that are gaining traction within the scientific community. As a prominent provider of ...

NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced that Kostas Biliouris has ...